Skip to main content

Events

NextGen Clinical Trial Investigator Training - Session 4, Oct. 4

The NextGen Clinical Trial Investigator Training is a virtual five-session educational program designed for investigators who currently lead or would like to lead clinical trials. The series includes lectures and panel discussions from leaders across the University of Missouri System, as well as Washington University, to define the regulatory, operational and ethical components of clinical trials, with the goal of developing a skilled workforce that provides the highest level of patient safety, teamwork and data quality. The program also covers institution-specific resources for investigators.

Timeframe: Five weeks, starting Sept. 13 through Oct. 11

  • 5-6:30 p.m. - virtual session program
  • Additional videos to view to complete coursework

Follow the links below for speaker information at each session.

Sept. 13 - Session 1: What is a Clinical Trial & Patient Perspective
Sept. 20 - Session 2: Audit Ready Trials & Lessons Learned
Sept. 27 - Session 3: Patient Recruitment & Informed Consent
Oct. 4 - Session 4: Responsible Conduct of Research & Organizing Your Study Team
Oct. 11 - Session 5: Institutional Resources 

Session 4: Responsible Conduct of Research & Organizing Your Study Team

Michele Kennett
Kennett
  
    RCR: Case Scenarios—Michele Kennett, JD, Associate Vice Chancellor for Research, Research Compliance, MU
Michelle Jenkerson
Jenkerson
  
    Clinicaltrials.gov: Case Scenarios—Michelle Jenkerson, RPA, Rn, Associate Director, Clinical Research, Center for Clinical Studies, Washington University-St. Louis
 
Stacee Baker
Baker
James Cook
Cook

 

    Organizing your Study Team—Stacee Baker, RN, Director of Research Operations and Planning, Department of Orthopaedic Surgery MU, James Cook, DVM, PhD, William & Kathryn Allen Distinguished Chair in Orthopaedic Surgery, Director, Thompson Laboratory for Regenerative Orthopaedics, Chief, Orthopaedic Research Division, and Director of Operations & Research, Mizzou BioJoint Center, MU
James McClay
McClay
  

 

   

Clinical Data & Engagement Methods—James McClay, MD, MS, FACEP, FAMIA, Professor, Health Management & Informatics, Chief Research Informatics Officer, School of Medicine, MU

 
Richard Barohn
Barohn
  Myths & Realities of Research Funding—Rick Barohn, MD, Executive Vice Chancellor for Health Affairs, Executive Director, NextGen Precision Health and Hugh E. and Sarah D. Stephenson Dean, School of Medicine, MU

 

Continuing Professional Education Credit

Successful Completion of this activity, which includes participating in the educational offering, participating in the evaluation process and completing the verification of attendance, enables the learner to satisfy the requirements for continuing education.

Nursing Contact Hours

University of Missouri Sinclair School of Nursing is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). 

1.0 contact hour may be awarded.

Physicians

The University of Missouri School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

The University of Missouri School of Medicine designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Financial Relationships

Current ACCME and Midwest Multistate Division, ANCC rules state that participants in continuing education activities should be made aware of any relevant affiliation or financial interest in the previous 24 months that may affect the planning of an educational activity or a speaker’s presentation(s). Each planning committee member and speaker has been requested to complete a financial relationship reporting form for the NextGen Precision Health Discovery Series. No planning committee member or speaker has a relevant financial interest.